AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to halt rare organ disease
Disease control Not yet recruitingThis study tests whether adding the drug belantamab mafodotin to standard chemotherapy can improve outcomes for adults newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 60 participants will receive different doses of the combina…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Heart rehab trial aims to boost exercise in amyloidosis patients
Symptom relief Not yet recruitingThis study tests whether a 5-week cardiac rehabilitation program can improve exercise capacity and quality of life in adults with cardiac amyloidosis. Participants will undergo exercise tests and heart function assessments before and after the program. The goal is to see if the p…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 11, 2026 11:57 UTC